Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • SARS-CoV
    (8)
  • DNA/RNA Synthesis
    (5)
  • Drug Metabolite
    (2)
  • HCV Protease
    (2)
  • RSV
    (2)
  • Nucleoside Antimetabolite/Analog
    (1)
  • Others
    (4)
TargetMol | Tags By ResearchField
  • Infection
    (4)
  • Respiratory System
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

gs 441524

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    10
    TargetMol | All_Pathways
  • Isotope Products
    2
    TargetMol | Isotope_Products
  • Reference Standards
    1
    TargetMol | Standard_Products
  • GS-441524
    T72221191237-69-0
    GS-441524 treatment of cats with naturally occurring feline infectious peritonitis.
    • $34
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • E197
    E 197
    T696562378515-04-7In house
    E197 is an anti-osteoporotic compound, a Dock5 inhibitor, which can be used in the study of osteoporosis.
    • $373
    In Stock
    Size
    QTY
  • GS-441524 tris-isobutyryl ester
    T364402563617-99-0
    GS-441524tris-isobutyryl ester is a prodrug form of the antiviral nucleoside analog and remdesivir metabolite GS-441524 .1It reduces the cytopathic effect of respiratory syncytial virus (RSV) in infected HEp-2 cells with an EC50value of 0.26 μM. 1.Mackman, R.L., Hui, H.C., Perron, M., et al.Prodrugs of a 1'-CN-4-aza-7,9-dideazaadenosine C-nucleoside leading to the discovery of remdesivir (GS-5734) as a potent inhibitor of respiratory syncytial virus with efficacy in the african green monkey model of RSVJ. Med. Chem.64(8)5001-5017(2021)
    • $265
    35 days
    Size
    QTY
  • GS-441524 HCl
    T696572378280-82-9
    GS-441524 is a potent inhibitor of feline infectious peritonitis (FIP) virus with an EC50 of 0.78 μM.. GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. GS-441524 is a molecular precursor to a pharmacologically active nucleoside triphosphate molecule. These analogs act as an alternative substrate and RNA-chain terminator of viral RNA dependent RNA polymerase. GS-441524 was non-toxic in feline cells at concentrations as high as 100 uM and effectively inhibited FIPV replication in cultured CRFK cells and in naturally infected feline peritoneal macrophages at concentrations as low as 1 uM. Note: GS-441524 is an active metabolite of Remdesivir.
    • $1,520
    1-2 weeks
    Size
    QTY
  • GS-441524-d
    TMIT-04062647440-98-8
    GS-441524-d is a deuterium-labeled form of GS-441524. GS-441524 is the primary active metabolite of Remdesivir, exhibiting superior activity compared to Remdesivir and demonstrating comparable efficacy in cell models of primary human lung and feline cells infected with viruses. It shows strong inhibitory effects on feline infectious peritonitis virus (FIPV), with an EC50 value of 0.78 μM.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • Gs 441524-[13C5] (Standard)
    TMSM-5198
    Gs 441524-[13C5] (Standard) is a reference standard of Gs 441524-[13C5] intended for quantitative analysis, quality control, and related biochemical research applications.
    • $7,030
    4-6 weeks
    Size
    QTY
  • GS-443902
    T55391355149-45-9
    GS-441524 was shown to be a safe and effective treatment for feline infectious peritonitis (FIP). The optimum dosage was found to be 4.0 mg/kg SC q24h for at least 12 weeks
    • Inquiry Price
    Inquiry
    Size
    QTY
  • GS-443902 trisodium
    Remdesivirmetabolitetrisodium, GS-441524triphosphatetrisodium
    T387611355050-21-3In house
    GS-443902 trisodium (GS-441524 triphosphate trisodium), the active triphosphate metabolite of Remdesivir (GS-5734), serves as a potent inhibitor of viral RNA-dependent RNA-polymerases (RdRp), displaying inhibitory concentrations (IC50) of 1.1 μM for RSV RdRp and 5 μM for HCV RdRp.
    • Inquiry Price
    10-14 weeks
    Size
    QTY
  • GS-621763
    T402762647442-13-3
    GS-621763, a prodrug of GS-441524, exhibits antiviral activity against SARS-CoV-2 pathogenesis.
    • $64
    In Stock
    Size
    QTY
  • SHEN26
    ATV014
    T873872691076-98-7
    SHEN26 (ATY014) is a potent, orally active RdRp inhibitor with an IC50 of 1.36 μM for SARS-CoV-2. As a 5'-cyclohexanecarboxylate derivative of GS-441524, SHEN26 inhibits viral nucleic acid synthesis, achieving antiviral effects. SHEN26 can be used for COVID-19 research [1] [2].
    • Inquiry Price
    10-14 weeks
    Size
    QTY